Coagulation Factor IXa, Factor X, and von Willebrand Factor (FIXa, FX, VWF)

Coagulation factor IXa, coagulation factor X, and von Willebrand factor are central components of the hemostasis system. Factor IXa forms a complex with factor VIII and phospholipids to activate factor X, which, once converted to factor Xa, drives the final common pathway of clot formation by converting prothrombin to thrombin. Von Willebrand factor facilitates platelet adhesion to damaged vascular sites and stabilizes factor VIII, supporting clot formation. Deficiency or dysfunction of any of these proteins leads to serious bleeding disorders (hemophilia B, hemophilia A, von Willebrand disease), while their dysregulation can contribute to thrombosis and other pathological clotting events.

Other names

activated factor IXFIXaStuart-Prower factorFXVWFWillebrand factor

Inhibition of enzymatic activity: Inhibitors (e.g., DOACs, heparins) block the protease action of factor IXa and factor Xa. Replacement therapy: Supplying deficiency with recombinant or plasma-derived factor IX, factor X, or VWF. Augmentation of activity: Agents like desmopressin trigger VWF release from endothelium.